Oncorus ONCR Stock
0 USD
{{ price }}
%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
0 USD
LOW - HIGH [24H]
-
USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Oncorus Price Chart
Oncorus ONCR Financial and Trading Overview
| Oncorus stock price | USD |
| Previous Close | 0.08 USD |
| Open | 0.08 USD |
| Bid | 0 USD x 40000 |
| Ask | 0 USD x 800 |
| Day's Range | 0.07 - 0.08 USD |
| 52 Week Range | 0.07 - 1.7 USD |
| Volume | 3.58M USD |
| Avg. Volume | 1.35M USD |
| Market Cap | 2.02M USD |
| Beta (5Y Monthly) | 2.847576 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
ONCR Valuation Measures
| Enterprise Value | 26.43M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.10929578 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.06504611 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.379 |
Trading Information
Oncorus Stock Price History
| Beta (5Y Monthly) | 2.847576 |
| 52-Week Change | -94.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.7 USD |
| 52 Week Low | 0.07 USD |
| 50-Day Moving Average | 0.26 USD |
| 200-Day Moving Average | 0.49 USD |
ONCR Share Statistics
| Avg. Volume (3 month) | 1.35M USD |
| Avg. Daily Volume (10-Days) | 6.81M USD |
| Shares Outstanding | 26.09M |
| Float | 15.25M |
| Short Ratio | 0.74 |
| % Held by Insiders | 12.69% |
| % Held by Institutions | 55.29% |
| Shares Short | 447.72K |
| Short % of Float | 1.95% |
| Short % of Shares Outstanding | 1.71% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.24% |
| Return on Equity (ttm) | -124.55% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -69700000 USD |
| Net Income Avi to Common (ttm) | -90541000 USD |
| Diluted EPS (ttm) | -3.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.98M USD |
| Total Cash Per Share (mrq) | 1.72 USD |
| Total Debt (mrq) | 69.25M USD |
| Total Debt/Equity (mrq) | 222.52 USD |
| Current Ratio (mrq) | 1.5 |
| Book Value Per Share (mrq) | 1.193 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -55698000 USD |
| Levered Free Cash Flow (ttm) | -53753752 USD |
Profile of Oncorus
| Country | United States |
| State | DE |
| City | Delaware |
| Address | 4 Corporate Drive |
| ZIP | 01810 |
| Phone | 339-240-3330 |
| Website | https://www.oncorus.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 64 |
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Q&A For Oncorus Stock
What is a current ONCR stock price?
Oncorus ONCR stock price today per share is USD.
How to purchase Oncorus stock?
You can buy ONCR shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncorus?
The stock symbol or ticker of Oncorus is ONCR.
Which industry does the Oncorus company belong to?
The Oncorus industry is Biotechnology.
How many shares does Oncorus have in circulation?
The max supply of Oncorus shares is 0.
What is Oncorus Price to Earnings Ratio (PE Ratio)?
Oncorus PE Ratio is now.
What was Oncorus earnings per share over the trailing 12 months (TTM)?
Oncorus EPS is 0 USD over the trailing 12 months.
Which sector does the Oncorus company belong to?
The Oncorus sector is Healthcare.
Oncorus ONCR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| NASDAQ Global Market Composite NQGM | 1952.45 USD — |
-0.14
|
— — | 1922.5 USD — | 1956.75 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4084.75 USD — |
+0.07
|
— — | 4033.52 USD — | 4091.93 USD — | — - | — — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}